Friday, November 24, 2017

Posts tagged with the keyword: ‘Cyclacel’

Three Small Cap Biotechs Primed For Corrections Following ASCO

Three Small Cap Biotechs Primed For Corrections Following ASCO

The month of May has thus far been a very profitable one for investors in a number of small cap biotechs leading up to the June 2011 ASCO meeting, particularly ones that haven’t consequently fared too well once their respective binary events had met its endpoints. First up on the list is Oxigene, Inc. (NASDAQ:OXGN), […]

Healthcare Movers: Cepheid, Hi-Tech, Arena, Cell Therapeutics, Compugen, Cyclacel, DARA, Endo

Healthcare Movers: Cepheid, Hi-Tech, Arena, Cell Therapeutics, Compugen, Cyclacel, DARA, Endo

Below is a list of the companies that made news in the healthcare sector on Friday, July 2, 2010. Cepheid (NASDAQ:CPHD) after the market close today announced that the company is initiating a recall of all lots of Xpert® MRSA/SA BC (blood culture) product. The recall is a corrective action, which does not require return […]

Healthcare Updates: Cardiome, Bio-Path, AstraZeneca, Cyclacel, Celgene

Healthcare Updates: Cardiome, Bio-Path, AstraZeneca, Cyclacel, Celgene

The following companies made the news for the Health Care Industry on Monday, June, 28, 2010 Cardiome, (NASDAQ:CRME): BRINAVESS, Intravenous or IV Vernakalant announced, EMA issued positive opinion for marketing approval for conversion of recent onset atrial fibrillation to sinus rhythm in adults, marketing authorization is expected later this year and will include  27 EU […]

Pharmaceutical Company Updates: Cyclacel, MannKind, Human Genome, BioTime, Bristol-Myers, RXi Pharma

Pharmaceutical Company Updates: Cyclacel, MannKind, Human Genome, BioTime, Bristol-Myers, RXi Pharma

Below is a list of the companies that made news in the healthcare sector on Thursday, June 10, 2010. Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) announced today interim response data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes (also called MDS, and formerly known […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo